In the present analysis, increased serum levels of Ang-2 were detected in lung cancer patients when compared with healthy controls, while higher baseline serum levels of Ang-2 were also identified in NSCLC and SCLC histological groups compared with healthy individuals, thus supporting the previous findings [16,17,18,25,26,27] (Table 2). This evidence concerns the gene ANGPT2 and lung cancer.